Predictive Oncology Inc. (POAI) operates in the biotech sector focusing on AI-driven drug discovery, particularly for cancer treatments. The company's financial ratios show strong compliance with debt and liquidity thresholds across major Shariah standards, with impure income at 4.88% just below the 5% limit. Business activities are permissible under Islamic principles, with no non-compliant revenue sources identified. However, due to its small market capitalization and liquidity, POAI is not included in major Shariah indices. Overall, while financially compliant, the lack of index inclusion results in a non-compliant status, with a BB quality rating indicating solid fundamentals but limited validation.